^
BIOMARKER:

BTK C481

i
Other names: BTK, Bruton Tyrosine Kinase, Bruton Agammaglobulinemia Tyrosine Kinase, Tyrosine-Protein Kinase BTK, Bruton'S Tyrosine Kinase, B-Cell Progenitor Kinase, AGMX1, ATK, BPK, Tyrosine-Protein Kinase BTK Isoform (Lacking Exon 13 To 17), Dominant-Negative Kinase-Deficient Brutons Tyrosine Kinase, Tyrosine-Protein Kinase BTK Isoform (Lacking Exon 14), Truncated Bruton Agammaglobulinemia Tyrosine Kinase, Agammaglobulinaemia Tyrosine Kinase, Agammaglobulinemia Tyrosine Kinase, PSCTK1, IGHD3, IMD1, XLA, AT
Entrez ID:
Related biomarkers:
Phase 1
Nurix Therapeutics, Inc.
Recruiting
Last update posted :
07/19/2022
Initiation :
05/05/2021
Primary completion :
10/01/2023
Completion :
11/01/2023
TP53 • CD4
|
TP53 mutation • BTK C481
|
Invega Sustenna (paliperidone palmitate extended-release 1-month injection) • NX-2127
Phase 1/2
ArQule, Inc. (a wholly owned subsidiary of Merc...
Active, not recruiting
Last update posted :
03/11/2022
Initiation :
06/26/2017
Primary completion :
09/01/2023
Completion :
09/01/2023
BCL2 • BCL6
|
BCL6 translocation • BTK C481 • BTK mutation
|
Invega Sustenna (paliperidone palmitate extended-release 1-month injection) • nemtabrutinib (MK-1026)